Using a blood test to improve clot prevention in burn patients
Part of Blood & lymphatic, Injuries & trauma clinical trials.
This study tests if using a blood test called anti-factor Xa helps doctors give the right amount of blood-thinning medicine to prevent clots in burn patients. It's for adults with moderate-to-large burns who need clot prevention while in the intensive care unit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 21 years or older.
- Your burn must cover 20% to 59% of your body.
- You must arrive at the burn unit within 48 hours of the burn.
- You need a medicine to prevent blood clots because you can't move much or are having surgery.
- You cannot have a bleeding problem or be taking blood thinners before the burn.
- You don't have severe health problems like kidney failure, advanced cancer, or liver disease.
- Your weight must be between 100 and 330 pounds (45–150 kg).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a blood test measuring a substance called anti-factor Xa activity can help predict dangerous blood clots in critically ill patients. If you join, researchers will follow you to see if the test results can prevent clots.
This trial tests whether a daily injection of a blood-thinning medicine called enoxaparin (Lovenox) can safely prevent dangerous blood clots in teens who are critically ill in the intensive care unit with an IV line and an infection or inflammation. It may help reduce the risk of blood clots without causing excess bleeding.
This trial tests whether starting enoxaparin (a blood-thinner) within 24 hours after placing a specific type of central line can prevent dangerous clots. It may help reduce clot risk in people whose line is placed in the neck or thigh vein, while also tracking bleeding side effects.
This trial tests whether continuing a lower dose of blood thinners can prevent another blood clot in cancer patients who have had a clot in an arm or chest catheter. It may help find a safer way to prevent future clots.
This study looks at a prevention plan to reduce the risk of hospital-acquired blood clots. It may help people who are expected to stay in the hospital for several days but do not already have a clot.
This study looks at how well blood thinners (anticoagulants) work in people with cancer who have had a blood clot. It aims to compare the benefits and risks of different anticoagulant medicines.
Hear when a new Venous Thromboembolic Event trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.